🎉 Congratulations! If you've got this POAP, you’re officially in the exclusive club of folks who are ready to break free from the Bayer CloudTech UserGroup email chain! 🥳 Time to wave goodbye to those inbox notifications! ✌️💌

You were invited to our Q4/2024 Townhall, where we explored our future organization based on what has been agreed upon until then. Updates from our Leadership Team included insights from the PH Strategy Summit, which did initiate discussions on our financials and the strategic mid- and long-term outcomes for Pharma. Additionally, we reflected on the results of the Ownership Pulse (formerly known as Employee Voice), discussed further considerations, and allocated time for a Q&A session. This token serves as appreciation for and proof of your participation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

Thank you for attending today's DT & IT Pharma Townhall! Looking at the past year with excitement and much to learn, we came together for the following agenda: - Opening Bijoy & Patrick with Q&A (30 min)​ - PH IT Award 2023 celebration with Bijoy and the LT (25 min)​ - OKR 2024 (20 min)​ - Q&A (15 min) Curious who won the PH IT Award 2023?? Well, here we go! Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Age-Related Macular Degeneration (AMD) Awareness Month is observed to highlight the impact of AMD, a leading cause of vision loss among individuals aged 50 and older. Affecting the macula, the central part of the retina, AMD compromises sharp, central vision necessary for activities like reading and driving. There are two types of AMD: dry (atrophic) and wet (neovascular). Dry AMD is more common and progresses slowly, while wet AMD is characterized by rapid vision loss due to abnormal blood vessel growth. Globally, AMD impacts approximately 196 million people. The prevalence of AMD increases with age; about 30% of individuals over the age of 75 are affected. Genetics, race (more prevalent among Caucasians), and smoking, influence the risk of developing AMD. AMD was discovered in the 19th century, but it was only in the late 20th century that significant advancements in understanding and treating the condition were made. Detailed examination of the retina, facilitated by evolving imaging technologies, has been crucial in diagnosing AMD. Treatments vary by type but may include lifestyle changes, vitamin supplements for certain stages of dry AMD, and anti-VEGF therapy for wet AMD. Despite ongoing research, there is unfortunately no cure for AMD yet, making awareness, early detection, and preventive strategies key to managing its impact on vision and quality of life. More: https://en.wikipedia.org/wiki/Macular_degeneration Art&Text supported by ChatGPT.

Thank you for joining our first DSO Open Mic session in 2024!! These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded.